Shimadzu Corporation

Shimadzu Corporation

SHMZF
Shimadzu CorporationUS flagOther OTC
24.49
USD
- -
- -
7.08BMarket Cap
Shimadzu Corporation
SHMZF
(Other OTC)

Recent

price

24.49

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
856.51
902.57
895.17
1,042.7
1,067.16
1,160.68
1,161.61
1,277.82
1,328.09
1,308.51
1,335.6
1,453.16
1,636.56
1,736.98
1,839.89
- -
924.3
Revenue per Share
34.05
30.79
25.69
32.97
62.55
81.05
89.79
101.26
110.41
107.84
122.52
160.49
176.63
193.54
183.55
- -
103.45
Basic EPS, GAAP
84.71
4.64
14.54
-62.17
87.34
71.27
63.07
99.24
29.43
80.26
171.37
180.67
106.78
49.63
125.95
- -
- -
Free Cash Flow per Basic Share
7.48
8.02
8.5
9
9.5
16.98
18.98
20.99
26.01
30.01
30
39
50.04
55.96
62.29
- -
- -
Dividend per Share
447.03
469.89
487.17
495.07
547.72
611.84
681.88
762.51
846.83
923.06
983
1,104.38
1,230.93
1,367.64
1,496.24
- -
1,403.34
Book Value per Share
507.93
523.22
565.48
593.46
687.42
720.38
791.06
878.36
940.73
989.02
1,099.32
1,255.76
1,379.65
1,609.48
1,618.96
- -
1,589.07
Tangible Book Value per Share
295
295
295
295
295
295
295
295
295
295
295
295
295
295
293
289
295
Basic Weighted Avg Shares
252,707
266,255
264,048
307,532
314,702
342,236
342,479
376,530
391,213
385,443
393,499
428,175
482,240
511,895
539,047
- -
272,381
Sales/Revenue/Turnover
6.45
7.27
4.59
7.81
8.64
10.43
10.83
11.37
11.37
10.86
12.64
14.9
14.15
14.21
13.3
- -
14.78
Operating Margin (%)
7,924
7,969
7,909
8,050
7,951
9,425
9,546
10,591
11,506
13,256
15,536
16,205
17,524
18,551
19,895
- -
- -
Depreciation Expense
10,046
9,083
7,578
9,724
18,445
23,899
26,473
29,838
32,523
31,766
36,097
47,289
52,048
57,037
53,776
- -
30,487
Net Income, GAAP
30.72
49.68
37.82
28.62
30.91
29.55
26.53
28.38
27.02
26.33
27.54
28.29
26.52
25.89
25.03
- -
25.76
Effective Tax Rate (%)
3.98
3.41
2.87
3.16
5.86
6.98
7.73
7.92
8.31
8.24
9.17
11.04
10.79
11.14
9.98
- -
11.19
Profit Margin (%)
103,176
100,240
109,952
102,679
134,182
144,079
158,933
162,258
157,628
170,166
191,350
235,620
259,122
308,425
303,169
- -
302,492
Working Capital
21,991
12,683
13,024
2,493
17,628
17,545
17,406
17,487
2,575
3,552
5,226
6,627
6,631
6,884
6,844
- -
6,563
LT Debt
156,653
161,568
173,429
181,993
210,015
219,969
241,627
268,059
287,940
302,773
335,502
381,162
423,498
492,333
498,064
- -
490,530
Total Equity
5.86
5.03
3.74
7.66
7.79
10.29
10.59
10.86
10.64
9.82
10.78
12.09
11.81
11.26
10.43
- -
6.08
Return on Invested Capital (%)
6.31
5.55
4.5
5.25
9.46
12.25
12.48
12.72
12.58
11.58
12.51
14.89
14.7
14.51
12.48
- -
7.49
Return on Capital (%)
7.85
6.72
5.37
6.71
12
13.98
13.88
14.02
13.72
12.19
12.86
15.38
15.13
14.9
12.78
- -
7.69
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
5,030
- -
5,140
LT Borrowings
66
- -
34
LT Finance Leases
6,818
- -
6,529
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
295
- -
294
Market Capitalization
- -
- -
953,915

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
466,936
- -
439,802
Cash, Cash Equivalents & STI
165,285
- -
157,132
Accounts Receivable, Net
144,808
- -
125,793
Inventories
141,772
- -
140,478
Total Current Liabilities
158,511
- -
137,310
Payables & Accruals
- -
- -
- -
ST Debt
5,030
- -
5,140
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
109,200
130,314
126,109
146,272
511,895
2025
- -
- -
- -
- -
539,047
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
37.67
- -
- -
- -
193.54
2025
- -
- -
- -
- -
183.55
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
55.96
2025
- -
- -
- -
- -
62.29
2026
- -
- -
- -
- -
- -
Business
Shimadzu Corporation manufactures and sells analytical and measuring instruments, medical systems, vacuum and industrial machinery including marine devices, hydraulic equipment, aircraft equipment, and optical devices; its analytical instruments support research, development, and quality control in pharmaceuticals, life sciences, and environmental measurement, while medical systems aid early cancer detection and treatment, industrial machinery advances semiconductor production, hydraulic components power machinery and vehicles, aircraft equipment ensures safe flight operations, and optical devices enhance equipment performance. Founded in 1875 and headquartered in Kyoto, Japan, the company operates globally with subsidiaries and facilities across North America, Europe, Asia, and Latin America, serving industries from healthcare and life sciences to aerospace and semiconductors. In November 2025, Shimadzu enters a strategic partnership with Japan Activation Capital to drive sustainable growth and corporate value enhancement under its medium-term plan through 2025, leveraging JAC's expertise in manufacturing strategies and overseas expansion; earlier in 2024-2025, it expands its biopharma collaboration with Sepragen Corporation to India for exclusive sales of bioprocess chromatography systems, alongside investments via its Shimadzu Future Innovation Fund and ongoing R&D expansions in pharmaceuticals and digital transformation.

Company News

MCPAPIChat
  • Hexagon (OTCMKTS:HXGBY) vs. Shimadzu (OTCMKTS:SHMZF) Critical Review